Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Universitätsmedizin Mannheim
Quality Control Registry of a standard treatment with intraoperative radiotherapy during breast conserving surgery with 20 Gy at the applicator surface as an advanced boost followed by a shortened external beam radiotherapy. This is a prospective phase IV study to evaluate real life data of IORT Boost. Study runs in Germany with 13 active centers recruiting. Due to the nature of the study (registry) there is no need for randomization. Inclusion of n = \>1000 patients is planned.
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Tumor diameter \< 3,5 cm
Informed consent
You may not be if
No informed consent
Tumor size \> 3,5 cm
No indication for a boost
Clareo Health | TARGeted Intraoperative radioTherapy With INTRABEAM as a Boost for Breast Cancer - A Quality Control Registry